• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从隐形眼镜中缓释抗硫酸乙酰肝素肽可抑制单纯疱疹病毒-1角膜感染。

Extended Release of an Anti-Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection.

作者信息

Jaishankar Dinesh, Buhrman Jason S, Valyi-Nagy Tibor, Gemeinhart Richard A, Shukla Deepak

机构信息

Department of Bioengineering, University of Illinois at Chicago, Chicago, Illinois, United States 2Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States 3Department of Pathology, University of.

Department of Biopharmaceutical Sciences, University of Illinois at Chicago, Chicago, Illinois, United States.

出版信息

Invest Ophthalmol Vis Sci. 2016 Jan 1;57(1):169-80. doi: 10.1167/iovs.15-18365.

DOI:10.1167/iovs.15-18365
PMID:26780322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4727529/
Abstract

PURPOSE

To prolong the release of a heparan sulfate binding peptide, G2-C, using a commercially available contact lens as a delivery vehicle and to demonstrate the ability of the released peptide to block herpes simplex virus-1 (HSV-1) infection using in vitro, ex vivo, and in vivo models of corneal HSV-1 infection.

METHODS

Commercially available contact lenses were immersed in peptide solution for 5 days prior to determining the release of the peptide at various time points. Cytotoxicity of the released samples was determined by MTT and cell cycle analysis, and the functional activity of the released samples were assessed by viral entry, and viral spread assay using human corneal epithelial cells (HCE). The ability to suppress infection in human and pig cornea ex vivo and mouse in vivo models were also assessed.

RESULTS

Peptide G2-C was released through the contact lens. Following release for 3 days, the peptide showed significant activity by inhibiting HSV-1 viral entry and spread in HCE cells. Significant suppression of infection was also observed in the ex vivo and in vivo experiments involving corneas.

CONCLUSIONS

Extended release of an anti-HS peptide through a commercially available contact lens can generate significant anti-HSV-1 activity and provides a new and effective way to control corneal herpes.

摘要

目的

使用市售隐形眼镜作为递送载体来延长硫酸乙酰肝素结合肽G2-C的释放,并使用角膜单纯疱疹病毒-1(HSV-1)感染的体外、离体和体内模型来证明释放的肽阻断HSV-1感染的能力。

方法

在确定肽在各个时间点的释放之前,将市售隐形眼镜浸入肽溶液中5天。通过MTT和细胞周期分析确定释放样品的细胞毒性,并使用人角膜上皮细胞(HCE)通过病毒进入和病毒传播试验评估释放样品的功能活性。还评估了在人角膜和猪角膜离体模型以及小鼠体内模型中抑制感染的能力。

结果

肽G2-C通过隐形眼镜释放。释放3天后,该肽通过抑制HSV-1病毒进入和在HCE细胞中的传播显示出显著活性。在涉及角膜的离体和体内实验中也观察到感染受到显著抑制。

结论

通过市售隐形眼镜延长抗HS肽的释放可产生显著的抗HSV-1活性,并提供了一种控制角膜疱疹的新的有效方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/4727529/39d2eaadd967/i1552-5783-57-1-169-f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/4727529/c6b77dc6508b/i1552-5783-57-1-169-f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/4727529/dc0ca5c856a4/i1552-5783-57-1-169-f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/4727529/d2d06d44b314/i1552-5783-57-1-169-f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/4727529/c16295111f1c/i1552-5783-57-1-169-f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/4727529/39d2eaadd967/i1552-5783-57-1-169-f05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/4727529/c6b77dc6508b/i1552-5783-57-1-169-f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/4727529/dc0ca5c856a4/i1552-5783-57-1-169-f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/4727529/d2d06d44b314/i1552-5783-57-1-169-f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/4727529/c16295111f1c/i1552-5783-57-1-169-f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df71/4727529/39d2eaadd967/i1552-5783-57-1-169-f05.jpg

相似文献

1
Extended Release of an Anti-Heparan Sulfate Peptide From a Contact Lens Suppresses Corneal Herpes Simplex Virus-1 Infection.从隐形眼镜中缓释抗硫酸乙酰肝素肽可抑制单纯疱疹病毒-1角膜感染。
Invest Ophthalmol Vis Sci. 2016 Jan 1;57(1):169-80. doi: 10.1167/iovs.15-18365.
2
Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.抗肝素硫酸盐肽可阻断体内单纯疱疹病毒感染。
J Biol Chem. 2011 Jul 15;286(28):25406-15. doi: 10.1074/jbc.M110.201103. Epub 2011 May 19.
3
Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy.单纯疱疹病毒1型感染后,HVEM促进小鼠角膜炎症和神经损伤,而免疫调节纳米颗粒疗法可改善这些症状。
Invest Ophthalmol Vis Sci. 2017 Jan 1;58(1):282-291. doi: 10.1167/iovs.16-20668.
4
Expression of herpes virus entry mediator (HVEM) in the cornea and trigeminal ganglia of normal and HSV-1 infected mice.在正常和 HSV-1 感染的小鼠角膜和三叉神经节中疱疹病毒进入介体(HVEM)的表达。
Curr Eye Res. 2009 Oct;34(10):896-904. doi: 10.3109/02713680903184250.
5
Atypical herpes simplex keratitis: frequency, clinical presentations and treatment results.非典型性单纯疱疹病毒性角膜炎:频率、临床表现和治疗结果。
Int Ophthalmol. 2020 Mar;40(3):659-665. doi: 10.1007/s10792-019-01226-1. Epub 2019 Nov 21.
6
Antiviral effects of Cacicol, a heparan sulfate biomimetic for corneal regeneration therapy, for herpes simplex virus type-1 and varicella zoster virus infection.用于角膜再生治疗的硫酸乙酰肝素仿生物Cacicol对单纯疱疹病毒1型和水痘带状疱疹病毒感染的抗病毒作用。
Antivir Ther. 2018;23(8):665-675. doi: 10.3851/IMP3254.
7
Expression, Inducers and Cellular Sources of the Chemokine MIG (CXCL 9), During Primary Herpes Simplex Virus Type-1 Infection of the Cornea.原发性单纯疱疹病毒1型角膜感染期间趋化因子MIG(CXCL 9)的表达、诱导剂及细胞来源
Curr Eye Res. 2015;40(8):800-8. doi: 10.3109/02713683.2014.957779. Epub 2014 Sep 10.
8
IL-1α Modulates IFN-γ-Induced Production of CXCL9/MIG during Herpes Simplex Virus Type-1 Corneal Infection.白细胞介素-1α在单纯疱疹病毒1型角膜感染期间调节γ干扰素诱导的CXCL9/MIG产生。
Curr Eye Res. 2021 Mar;46(3):309-317. doi: 10.1080/02713683.2020.1803921. Epub 2020 Sep 15.
9
In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection.聚六亚甲基双胍对单纯疱疹病毒感染的体外和体内作用
Cornea. 1997 Sep;16(5):556-9.
10
Degeneration and regeneration of corneal nerves in response to HSV-1 infection.针对 HSV-1 感染的角膜神经的变性和再生。
Invest Ophthalmol Vis Sci. 2015 Jan 13;56(2):1097-107. doi: 10.1167/iovs.14-15596.

引用本文的文献

1
The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis.角膜单纯疱疹病毒 1 感染和疱疹性基质性角膜炎的免疫生物学。
Clin Microbiol Rev. 2024 Sep 12;37(3):e0000624. doi: 10.1128/cmr.00006-24. Epub 2024 Jul 30.
2
Viral MicroRNAs in Herpes Simplex Virus 1 Pathobiology.单纯疱疹病毒 1 病毒发病机制中的病毒 microRNAs。
Curr Pharm Des. 2024;30(9):649-665. doi: 10.2174/0113816128286469240129100313.
3
Disease parameters following ocular herpes simplex virus type 1 infection are similar in male and female BALB/C mice.

本文引用的文献

1
Cell entry mechanisms of HSV: what we have learned in recent years.单纯疱疹病毒的细胞进入机制:我们近年来所了解到的情况。
Future Virol. 2015 Oct 1;10(10):1145-1154. doi: 10.2217/fvl.15.85.
2
In vitro-in vivo correlation for complex non-oral drug products: Where do we stand?复杂非口服药物产品的体外-体内相关性:我们目前的进展如何?
J Control Release. 2015 Dec 10;219:644-651. doi: 10.1016/j.jconrel.2015.09.052. Epub 2015 Sep 28.
3
A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model.
眼部单纯疱疹病毒 1 型感染后疾病参数在雄性和雌性 BALB/C 小鼠中相似。
PLoS One. 2023 Jun 15;18(6):e0287194. doi: 10.1371/journal.pone.0287194. eCollection 2023.
4
Soft Contact Lenses as Drug Delivery Systems: A Review.软性隐形眼镜作为药物传递系统:综述。
Molecules. 2021 Sep 14;26(18):5577. doi: 10.3390/molecules26185577.
5
Heparan Sulfate Binding Cationic Peptides Restrict SARS-CoV-2 Entry.硫酸乙酰肝素结合阳离子肽可限制新型冠状病毒2的进入。
Pathogens. 2021 Jun 24;10(7):803. doi: 10.3390/pathogens10070803.
6
Heparanase as a potential player in SARS-CoV-2 infection and induced coagulopathy.肝素酶在 SARS-CoV-2 感染和诱导的凝血功能障碍中的潜在作用。
Biosci Rep. 2021 Jul 30;41(7). doi: 10.1042/BSR20210290.
7
Pathobiology and treatment of viral keratitis.病毒性角膜炎的发病机制与治疗。
Exp Eye Res. 2021 Apr;205:108483. doi: 10.1016/j.exer.2021.108483. Epub 2021 Feb 6.
8
Herpes Simplex Virus Cell Entry Mechanisms: An Update.单纯疱疹病毒的细胞进入机制:最新进展
Front Cell Infect Microbiol. 2021 Jan 18;10:617578. doi: 10.3389/fcimb.2020.617578. eCollection 2020.
9
Therapeutic Ophthalmic Lenses: A Review.治疗性眼科镜片:综述
Pharmaceutics. 2020 Dec 28;13(1):36. doi: 10.3390/pharmaceutics13010036.
10
Advancement on Sustained Antiviral Ocular Drug Delivery for Herpes Simplex Virus Keratitis: Recent Update on Potential Investigation.单纯疱疹病毒性角膜炎持续抗病毒眼用药物递送的进展:潜在研究的最新进展
Pharmaceutics. 2020 Dec 22;13(1):1. doi: 10.3390/pharmaceutics13010001.
一种基于1型单纯疱疹病毒人无症状CD8 + T细胞表位的疫苗在“人源化”HLA转基因兔模型中可预防眼部疱疹。
Invest Ophthalmol Vis Sci. 2015 Jun;56(6):4013-28. doi: 10.1167/iovs.15-17074.
4
The use of human cornea organotypic cultures to study herpes simplex virus type 1 (HSV-1)-induced inflammation.利用人角膜器官型培养物研究单纯疱疹病毒1型(HSV-1)诱导的炎症。
Graefes Arch Clin Exp Ophthalmol. 2015 Oct;253(10):1721-8. doi: 10.1007/s00417-015-3073-4. Epub 2015 Jun 6.
5
Heparanase is a host enzyme required for herpes simplex virus-1 release from cells.乙酰肝素酶是单纯疱疹病毒-1从细胞中释放所必需的一种宿主酶。
Nat Commun. 2015 Apr 27;6:6985. doi: 10.1038/ncomms7985.
6
Diversity of heparan sulfate and HSV entry: basic understanding and treatment strategies.硫酸乙酰肝素的多样性与单纯疱疹病毒进入:基本认识与治疗策略
Molecules. 2015 Feb 5;20(2):2707-27. doi: 10.3390/molecules20022707.
7
Release kinetics study of poorly water-soluble drugs from nanoparticles: are we doing it right?难溶性药物从纳米颗粒中的释放动力学研究:我们做得对吗?
Mol Pharm. 2015 Mar 2;12(3):997-1003. doi: 10.1021/mp500817h. Epub 2015 Feb 17.
8
Peptide therapeutics: current status and future directions.肽类治疗药物:现状与未来方向。
Drug Discov Today. 2015 Jan;20(1):122-8. doi: 10.1016/j.drudis.2014.10.003. Epub 2014 Oct 17.
9
Characterization of a proteolytically stable D-peptide that suppresses herpes simplex virus 1 infection: implications for the development of entry-based antiviral therapy.一种抑制单纯疱疹病毒1型感染的蛋白水解稳定D-肽的特性:对基于病毒进入的抗病毒疗法开发的启示。
J Virol. 2015 Feb;89(3):1932-8. doi: 10.1128/JVI.02979-14. Epub 2014 Nov 26.
10
Topical delivery of ocular therapeutics: carrier systems and physical methods.眼部治疗药物的局部递释:载体系统和物理方法。
J Pharm Pharmacol. 2014 Apr;66(4):507-30. doi: 10.1111/jphp.12132. Epub 2013 Aug 28.